StopDownOpen the app

Stake sale · Healthcare & Life Sciences

Lightspeed India exits Innovaccer stake in 2025

By ·

Date
Company
Innovaccer
What it does
Healthcare data analytics platform
Kind
Stake sale
Based in
San Francisco
Founded
2014
Sector
Healthcare & Life Sciences

What they do

Innovaccer offers software across the healthcare value chain for providers and insurers

What happened

Lightspeed India sold its stake earlier in 2025, achieving over 30% IRR on its investment

Why it matters

Kaiser Permanente's entry into the cap table catalyzed Lightspeed's exit

The details

  • Lightspeed India exited its stake in Innovaccer earlier in 2025.
  • The exit was catalyzed by Kaiser Permanente entering Innovaccer's cap table.
  • Lightspeed India achieved over 30% IRR on its investment.
  • Lightspeed was an early institutional backer of Innovaccer.
  • Innovaccer raised a $275M Series F in January 2025 from B Capital Group, Banner Health, Danaher Ventures, Generation IM, Kaiser Permanente, and M12.
  • The Series F included both primary and secondary components to provide exits for early investors.
  • Innovaccer will use Series F funds to build multiple copilots and agents across clinical decision support, documentation, and care management.

The bigger picture

  • Innovaccer has faced challenges due to technology promises not meeting ecosystem demand and spreading too thin in healthcare software.
  • US venture capital remains bullish on niche healthcare AI applications, especially scribing (AI transcription for electronic health records).
  • McKinsey estimates US healthcare EBITDA will grow at 7% CAGR from $676B (2023) to $987B (2028).

About the business

  • Innovaccer offers solutions across the healthcare value chain: providers, customers, public health systems, and life sciences.
  • It serves 130 healthcare organizations, including six of the top 10 US health systems.
  • Revenue is rising 50% year-on-year; on track to hit $250M ARR in 2025.
  • India entity standalone revenue from operations: ₹350.9 crore in FY24.
  • India entity standalone profit: ₹32.6 crore in FY24.
  • Headquartered in San Francisco and Noida.

What happens next

  • Innovaccer will use Series F funds to build multiple copilots and agents across clinical decision support, documentation, and care management.

The deal

Type
stake-sale

Investors

  • Lightspeed India (seller) — Early institutional backer of Innovaccer.
  • Kaiser Permanente (participated) — One of the largest US healthcare providers, combining not-for-profit insurance with its own hospital network.

Founders

  • Abhinav Shashank, Co-founder
  • Kanav Hasija, Co-founder
  • Sandeep Gupta, Co-founder

About Innovaccer

Product
healthcare data and analytics platform that helps hospitals, health systems and insurers unify clinical, financial and operational data
Customers
Hospitals, health systems, and health insurers that buy software to unify data and automate care workflows
How it makes money
Subscription software and platform services for healthcare organizations
What sets it apart
Best-in-KLAS recognition across multiple categories and a broad healthcare data platform

Read it as a card in the app

More on Innovaccer

Everything on Innovaccer →

Same day

All startup news on 22 August 2025 →